MIR296 Gene

HGNC Family Non-coding RNAs
Name microRNA 296
Description microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nMicroRNA‐296 (miR‐296) has emerged as a multifunctional regulator in non‐neoplastic contexts. For example, during enterovirus 71 infection miR‐296‐5p is upregulated and acts directly on viral genomic sequences to inhibit replication, suggesting an important role in host antiviral defence. In addition, miR‐296 regulates vascular and renal homeostasis: it modulates hWNK4 expression in a cell‐specific manner—potentially impacting blood pressure regulation—and its loss, often via sequestration by sponging circular RNAs, contributes to diabetic renal fibrosis by permitting increased expression of proteins such as the sodium–glucose cotransporter SGLT2. Moreover, in models of osteoarthritis, downregulation of miR‐296 (particularly the ‐3p form) is associated with enhanced chondrocyte apoptosis and extracellular matrix catabolism through modulation of pathways such as TGF‑β1/CTGF/p38MAPK."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "5"}]}, {"type": "t", "text": ""}, {"type": "p", "children": [{"type": "t", "text": "\nIn multiple human cancers the miR‐296 family generally exhibits tumor‐suppressive functions. In parathyroid carcinoma and esophageal squamous cell cancer, decreased miR‐296 levels have been reported, suggesting that loss of miR‐296 contributes to malignant transformation. In prostate cancer, miR‐296‐5p directly targets Pin1 while in breast cancer its downregulation correlates with aberrant expression and mis‐localization of the cell‐polarity protein Scrib, each event being linked to enhanced tumor progression. Similar antiproliferative, anti‐migratory and anti‐stemness effects are observed in non–small cell lung cancer (NSCLC), triple‐negative breast cancer (via a ceRNA axis that regulates PLK1), clear cell renal cell carcinoma (by targeting SOX12) and hepatocellular carcinoma (through a Brg1/Sall4 axis). In nasopharyngeal carcinoma, miR‐296‐3p suppresses metastasis by targeting MK2 and modulating Ras/PI3K/Akt signaling, while in choroidal melanoma and certain colorectal and pancreatic cancers miR‐296 downregulation correlates with tumor aggressiveness. Moreover, in papillary thyroid carcinoma and cholangiocarcinoma, recent studies have demonstrated that deregulation of miR‐296—often by long noncoding RNA or circular RNA “sponges” (for example, AGAP2‐AS1, circPLK1 or circ_0000515)—perturbs key signaling pathways, thereby diminishing its suppressive control over oncogenic targets."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "6", "end_ref": "30"}, {"type": "fg_f", "ref": "3"}, {"type": "fg_f", "ref": "31"}, {"type": "fg_f", "ref": "4"}, {"type": "fg_f", "ref": "33"}]}, {"type": "t", "text": ""}, {"type": "p", "children": [{"type": "t", "text": "\nConversely, context‐dependent and even oncogenic functions have been reported for miR‐296. In immortalized cells, miR‐296 overexpression has been implicated in the suppression of p53 activity via targeting of the p21 3′‑UTR, thereby contributing to carcinogenesis. In certain glioblastoma models, the miR‐296‐5p isoform promotes invasiveness by directly inhibiting pro‑apoptotic and differentiation‐promoting targets such as caspase‑8 and the nerve growth factor receptor. In another glioma study, aberrantly high levels of miR‐296‑3p were found to downregulate inhibitors of the β‑catenin pathway (for instance, ICAT), thereby releasing oncogenic Wnt signaling and fostering aggressive cell cycle progression. These findings underscore that the net impact of miR‐296 on tumor biology depends on the cellular context and the balance of its interactions with various sponging noncoding RNAs and mRNA targets."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "35", "end_ref": "37"}, {"type": "fg_f", "ref": "29"}, {"type": "fg_f", "ref": "38"}]}]}]}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Jinyuan Mao, Chunyi Li, Yuanyuan Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Human with-no-lysine kinase-4 3'-UTR acting as the enhancer and being targeted by miR-296."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Biochem Cell Biol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biocel.2010.06.006"}], "href": "https://doi.org/10.1016/j.biocel.2010.06.006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20561597"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20561597"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Zhenhua Zheng, Xianliang Ke, Meng Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Human microRNA hsa-miR-296-5p suppresses enterovirus 71 replication by targeting the viral genome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Virol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/JVI.02655-12"}], "href": "https://doi.org/10.1128/JVI.02655-12"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23468506"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23468506"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Zhilin Cao, Wenguang Liu, Xiaoyi Qu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-296-5p inhibits IL-1β-induced apoptosis and cartilage degradation in human chondrocytes by directly targeting TGF-β1/CTGF/p38MAPK pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Cycle (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/15384101.2020.1750813"}], "href": "https://doi.org/10.1080/15384101.2020.1750813"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32378978"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32378978"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Zhibin Zhou, Jun Ma, Jiajia Lu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circular RNA CircCDH13 contributes to the pathogenesis of osteoarthritis via CircCDH13/miR-296-3p/PTEN axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Physiol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcp.30091"}], "href": "https://doi.org/10.1002/jcp.30091"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33037617"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33037617"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Sheng Chen "}, {"type": "b", "children": [{"type": "t", "text": "circ_000166/miR-296 Aggravates the Process of Diabetic Renal Fibrosis by Regulating the SGLT2 Signaling Pathway in Renal Tubular Epithelial Cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Dis Markers (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1155/2022/6103086"}], "href": "https://doi.org/10.1155/2022/6103086"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35615399"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35615399"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "S Corbetta, V Vaira, V Guarnieri, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Differential expression of microRNAs in human parathyroid carcinomas compared with normal parathyroid tissue."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Endocr Relat Cancer (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1677/ERC-09-0134"}], "href": "https://doi.org/10.1677/ERC-09-0134"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19926710"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19926710"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Liu Hong, Yu Han, Hongwei Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The prognostic and chemotherapeutic value of miR-296 in esophageal squamous cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ann Surg (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/SLA.0b013e3181dd4ea9"}], "href": "https://doi.org/10.1097/SLA.0b013e3181dd4ea9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20485139"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20485139"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Yifeng Bai, Hongzhan Liao, Tianzhu Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-296-3p regulates cell growth and multi-drug resistance of human glioblastoma by targeting ether-à-go-go (EAG1)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Cancer (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ejca.2012.08.020"}], "href": "https://doi.org/10.1016/j.ejca.2012.08.020"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22999387"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22999387"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Federica Savi, Irene Forno, Alice Faversani, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-296/Scribble axis is deregulated in human breast cancer and miR-296 restoration reduces tumour growth in vivo."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Sci (Lond) (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/CS20130580"}], "href": "https://doi.org/10.1042/CS20130580"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24527800"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24527800"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Kuen-Haur Lee, Forn-Chia Lin, Tai-I Hsu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-296-5p (miR-296-5p) functions as a tumor suppressor in prostate cancer by directly targeting Pin1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochim Biophys Acta (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbamcr.2014.06.001"}], "href": "https://doi.org/10.1016/j.bbamcr.2014.06.001"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24915000"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24915000"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Chun Xu, Sen Li, Tengfei Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-296-5p suppresses cell viability by directly targeting PLK1 in non-small cell lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2015.4392"}], "href": "https://doi.org/10.3892/or.2015.4392"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26549165"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26549165"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Zheng He, Lianhua Yu, Shiyi Luo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-296 inhibits the metastasis and epithelial-mesenchymal transition of colorectal cancer by targeting S100A4."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Cancer (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12885-017-3121-z"}], "href": "https://doi.org/10.1186/s12885-017-3121-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28209128"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28209128"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Hailing Li, Jilin Li, Baolin Shi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA‑296 targets AKT2 in pancreatic cancer and functions as a potential tumor suppressor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Med Rep (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/mmr.2017.6602"}], "href": "https://doi.org/10.3892/mmr.2017.6602"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28534950"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28534950"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Xiaojun Ma, Baoxiang Zhuang, Wentao Li "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA‑296‑5p downregulated AKT2 to inhibit hepatocellular carcinoma cell proliferation, migration and invasion."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Med Rep (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/mmr.2017.6701"}], "href": "https://doi.org/10.3892/mmr.2017.6701"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28586057"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28586057"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Xinhe Wang, Yuedong Hu, Jianyi Cui, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Coordinated targeting of MMP-2/MMP-9 by miR-296-3p/FOXCUT exerts tumor-suppressing effects in choroidal malignant melanoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biochem (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11010-017-3248-x"}], "href": "https://doi.org/10.1007/s11010-017-3248-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29260433"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29260433"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Xiaojie Deng, Zhen Liu, Xiong Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-296-3p Negatively Regulated by Nicotine Stimulates Cytoplasmic Translocation of c-Myc via MK2 to Suppress Chemotherapy Resistance."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Ther (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ymthe.2018.01.023"}], "href": "https://doi.org/10.1016/j.ymthe.2018.01.023"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29525743"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29525743"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Endi Xia, Sotaro Kanematsu, Yusuke Suenaga, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA induction by copy number gain is associated with poor outcome in squamous cell carcinoma of the lung."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-018-33696-1"}], "href": "https://doi.org/10.1038/s41598-018-33696-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30337605"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30337605"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Xiaotian Zhang, Xinju Zhang, Xiaomin Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-296, a suppressor non-coding RNA, downregulates SGLT2 expression in lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Oncol (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/ijo.2018.4599"}], "href": "https://doi.org/10.3892/ijo.2018.4599"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30365049"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30365049"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Xiaomin Liu, Yanmao Wang, Xiaotian Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-296-5p promotes healing of diabetic wound by targeting sodium-glucose transporter 2 (SGLT2)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diabetes Metab Res Rev (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/dmrr.3104"}], "href": "https://doi.org/10.1002/dmrr.3104"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30467970"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30467970"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "S-L Zhou, Q-L Tang, S-X Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-296-5p suppresses papillary thyroid carcinoma cell growth via targeting PLK1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.26355/eurrev_201903_17251"}], "href": "https://doi.org/10.26355/eurrev_201903_17251"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30915753"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30915753"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Yang Shi, Xiaohua Yang, Xiaofeng Xue, et al. "}, {"type": "b", "children": [{"type": "t", "text": "HANR promotes lymphangiogenesis of hepatocellular carcinoma via secreting miR-296 exosome and regulating EAG1/VEGFA signaling in HDLEC cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biochem (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcb.29036"}], "href": "https://doi.org/10.1002/jcb.29036"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31127654"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31127654"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "T Ge, H-C Wu, Y-Y Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-296-3p may affect the proliferation and migration of non-small cell lung cancer cells via regulating RABL3."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.26355/eurrev_201907_18321"}], "href": "https://doi.org/10.26355/eurrev_201907_18321"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31298353"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31298353"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Z-Z Wang, Y-R Luo, J Du, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-296-5p inhibits cell invasion and migration of esophageal squamous cell carcinoma by downregulating STAT3 signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.26355/eurrev_201906_18185"}], "href": "https://doi.org/10.26355/eurrev_201906_18185"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31298412"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31298412"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Yanan Kong, Lu Yang, Weidong Wei, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CircPLK1 sponges miR-296-5p to facilitate triple-negative breast cancer progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Epigenomics (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2217/epi-2019-0093"}], "href": "https://doi.org/10.2217/epi-2019-0093"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31337246"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31337246"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Yu Dong, Tao Xu, Shouping Zhong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circ_0076305 regulates cisplatin resistance of non-small cell lung cancer via positively modulating STAT3 by sponging miR-296-5p."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Life Sci (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.lfs.2019.116984"}], "href": "https://doi.org/10.1016/j.lfs.2019.116984"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31647948"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31647948"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Yonghui Chen, Hongbo Gao, Yaomei Li "}, {"type": "b", "children": [{"type": "t", "text": "Inhibition of LncRNA FOXD3-AS1 suppresses the aggressive biological behaviors of thyroid cancer via elevating miR-296-5p and inactivating TGF-β1/Smads signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Endocrinol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.mce.2019.110634"}], "href": "https://doi.org/10.1016/j.mce.2019.110634"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31678422"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31678422"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Zhuangfei Chen, Kanghua Xiao, Shijun Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circular RNA hsa_circ_001895 serves as a sponge of microRNA-296-5p to promote clear cell renal cell carcinoma progression by regulating SOX12."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Sci (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/cas.14261"}], "href": "https://doi.org/10.1111/cas.14261"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31782868"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31782868"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Dong-Min Shi, Xiao-Li Shi, Kai-Lin Xing, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-296-5p suppresses stem cell potency of hepatocellular carcinoma cells via regulating Brg1/Sall4 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Signal (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cellsig.2020.109650"}], "href": "https://doi.org/10.1016/j.cellsig.2020.109650"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32320856"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32320856"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Jing Zhou, Guobo Du, Hongmei Fu "}, {"type": "b", "children": [{"type": "t", "text": "miR‑296‑3p promotes the proliferation of glioblastoma cells by targeting ICAT."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Med Rep (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/mmr.2020.11011"}], "href": "https://doi.org/10.3892/mmr.2020.11011"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32323769"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32323769"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "J-L Ni, X-Q Dang, Z-B Shi "}, {"type": "b", "children": [{"type": "t", "text": "CircPSM3 inhibits the proliferation and differentiation of OA chondrocytes by targeting miRNA-296-5p."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.26355/eurrev_202004_20805"}], "href": "https://doi.org/10.26355/eurrev_202004_20805"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32329819"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32329819"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Fenglin Cai, Wenjie Fu, Lei Tang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hsa_circ_0000515 is a novel circular RNA implicated in the development of breast cancer through its regulation of the microRNA-296-5p/CXCL10 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS J (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/febs.15373"}], "href": "https://doi.org/10.1111/febs.15373"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32446265"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32446265"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Xian Zhao, Yanli Wang, Jianfeng He, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA UCA1 maintains the low-tumorigenic and nonmetastatic status by stabilizing E-cadherin in primary prostate cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Carcinog (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/mc.23247"}], "href": "https://doi.org/10.1002/mc.23247"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32805084"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32805084"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Meihui Chen, Chen Chen, Haiqing Luo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-296-5p inhibits cell metastasis and invasion in nasopharyngeal carcinoma by reversing transforming growth factor-β-induced epithelial-mesenchymal transition."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Mol Biol Lett (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s11658-020-00240-x"}], "href": "https://doi.org/10.1186/s11658-020-00240-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33292168"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33292168"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Chenlong Li, Yan Liu, Zhonghua Lv, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circular RNA circHECTD1 facilitates glioma progression by regulating the miR-296-3p/SLC10A7 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Physiol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcp.30277"}], "href": "https://doi.org/10.1002/jcp.30277"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33561315"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33561315"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "A-rum Yoon, Ran Gao, Zeenia Kaul, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-296 is enriched in cancer cells and downregulates p21WAF1 mRNA expression via interaction with its 3' untranslated region."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nucleic Acids Res (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/nar/gkr492"}], "href": "https://doi.org/10.1093/nar/gkr492"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21724611"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21724611"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Hong Lee, Su Jin Hwang, Hye Ree Kim, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Neurofibromatosis 2 (NF2) controls the invasiveness of glioblastoma through YAP-dependent expression of CYR61/CCN1 and miR-296-3p."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochim Biophys Acta (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbagrm.2016.02.010"}], "href": "https://doi.org/10.1016/j.bbagrm.2016.02.010"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26923924"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26923924"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Hong Lee, Chang Hoon Shin, Hye Ree Kim, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-296-5p Promotes Invasiveness through Downregulation of Nerve Growth Factor Receptor and Caspase-8."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cells (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.14348/molcells.2017.2270"}], "href": "https://doi.org/10.14348/molcells.2017.2270"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27927008"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27927008"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Junjie Chu, Li Tao, Teng Yao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circular RNA circRUNX1 promotes papillary thyroid cancer progression and metastasis by sponging MiR-296-3p and regulating DDHD2 expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41419-020-03350-8"}], "href": "https://doi.org/10.1038/s41419-020-03350-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33479208"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33479208"}]}]}]}
Synonyms MIRN296, MIR-296, MIRNA296
NCBI Gene ID 407022
API
Download Associations
Predicted Functions View MIR296's ARCHS4 Predicted Functions.
Co-expressed Genes View MIR296's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View MIR296's ARCHS4 Predicted Functions.

Functional Associations

MIR296 has 977 functional associations with biological entities spanning 6 categories (molecular profile, disease, phenotype or trait, functional term, phrase or reference, chemical, cell line, cell type or tissue, gene, protein or microRNA) extracted from 20 datasets.

Click the + buttons to view associations for MIR296 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR296 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
ChEA Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR296 gene from the CHEA Transcription Factor Binding Site Profiles dataset.
ChEA Transcription Factor Targets transcription factors binding the promoter of MIR296 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR296 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
CTD Gene-Disease Associations diseases associated with MIR296 gene/protein from the curated CTD Gene-Disease Associations dataset.
ENCODE Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at MIR296 gene from the ENCODE Histone Modification Site Profiles dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR296 gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of MIR296 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
ESCAPE Omics Signatures of Genes and Proteins for Stem Cells PubMedIDs of publications reporting gene signatures containing MIR296 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset.
GeneRIF Biological Term Annotations biological terms co-occuring with MIR296 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.
GeneSigDB Published Gene Signatures PubMedIDs of publications reporting gene signatures containing MIR296 from the GeneSigDB Published Gene Signatures dataset.
GEO Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of MIR296 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of MIR296 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset.
GTEx Tissue Gene Expression Profiles tissues with high or low expression of MIR296 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset.
GTEx Tissue Sample Gene Expression Profiles tissue samples with high or low expression of MIR296 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset.
JASPAR Predicted Transcription Factor Targets transcription factors regulating expression of MIR296 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR296 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
KnockTF Gene Expression Profiles with Transcription Factor Perturbations transcription factor perturbations changing expression of MIR296 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset.
MotifMap Predicted Transcription Factor Targets transcription factors regulating expression of MIR296 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at MIR296 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.